Title Physician

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

NCT ID : 02194738
Protocol Number : A151216
Phase : N/A
Location : Santa Monica, CA
Alison Conlin, M.D.

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, ALCHEMIST Chemo-IO Study

NCT ID : 04267848
Protocol Number : A081801
Phase : 3
Location : Santa Monica, CA
Alison Conlin, M.D.

Evaluating the Clinical Efficacy of an Early Stage Lung Cancer Detector

NCT ID : N/A
Protocol Number : CPC001-2017-S5P4-PSJHC
Phase : N/A
Location : Santa Monica, CA
Robert McKenna, M.D.

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

NCT ID : 03425643
Protocol Number : MK-7339-008
Phase : 3
Location : Santa Monica, CA
Dr. Timothy Kristedja

⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors

NCT ID : 03802123
Protocol Number : IAB-CD8-201
Phase : 2
Location : Santa Monica, CA
Dr. Przemyslaw Twardowski